Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship

European Urology

Volumn 69, Issue 2, 2016, Pages 276-283

  Cai, Tommaso ^a   Verze, Paolo ^b   Brugnolli, Anna ^c   Tiscione, Daniele ^a   Luciani, Lorenzo Giuseppe ^a   Eccher, Cristina ^a   Lanzafame, Paolo ^a   Malossini, Gianni ^a   Wagenlehner, Florian M E ^d   Mirone, Vincenzo ^b   Bjerklund Johansen, Truls E ^e   Pickard, Robert ^f   Bartoletti, Riccardo ^g  

^a Santa Chiara Regional Hospital   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY HOSPITAL GIESSEN   (Germany)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antimicrobial prophylaxis; Cost saving; Guidelines; Surgical urology; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL STRAIN; DRUG COST; ESCHERICHIA COLI; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; UROLOGY GUIDELINE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ECONOMICS; EUROPE; KLEBSIELLA; MIDDLE AGED; PROTOCOL COMPLIANCE; STANDARDS; UROLOGIC SURGERY; UROLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; EUROPE; FEMALE; GENTAMICINS; GUIDELINE ADHERENCE; HUMANS; KLEBSIELLA; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PRACTICE GUIDELINES AS TOPIC; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; UROLOGIC SURGICAL PROCEDURES; UROLOGY;

EID: 84952875872     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.05.010     Document Type: Article

References (31)

1. A. Sasse, R. Mertens, J.P. Sion, and et al. Surgical prophylaxis in Belgian hospitals: estimate of costs and potential savings J Antimicrob Chemother 41 1998 267 272
2. M. Grabe, T.E. Bjerklund-Johansen, H. Botto, and et al. Antibiotics M. Grabe, T.E. Bjerklund-Johansen, H. Botto, Guidelines on urological infections 2010 European Association of Urology Arnhem 69
3. M. Çek, Z. Tandoʇdu, K. Naber, and et al. Antibiotic prophylaxis in urology departments, 2005-2010 Eur Urol 63 2013 386 394
4. H.S. Gold, and R.C. Moellering Jr. Antimicrobial-drug resistance N Engl J Med 335 1996 1445 1453
5. S.E. Cosgrove The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs Clin Infect Dis 42 Suppl 2 2006 S82 S89
6. J. Ho, P.A. Tambyah, and D.L. Paterson Multiresistant Gram-negative infections: a global perspective Curr Opin Infect Dis 23 2010 546 553
7. A.M. Bal, and I.M. Gould Antibiotic stewardship: overcoming implementation barriers Curr Opin Infect Dis 24 2011 357 362
8. P. Gorecki, M. Schein, J.C. Rucinski, and L. Wise Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues World J Surg 23 1999 429 432
9. M. Grabe, T.E. Bjerklund-Johansen, H. Botto, and et al. Guidelines on urological infections 2010 European Association of Urology Arnhem http://uroweb.org/wp-content/uploads/Urological-Infections-2010.pdf
10. W.A. Altemeier, J.F. Burke, B.A. Pruitt, and W.R. Sandusky Manual on control of infection in surgical patients ed 2. 1984 JB Lippincott Philadelphia, PA
11. K.W. Clark, and D. Gray The defined daily dose as a tool in pharmacoeconomics. Advantages and limitation Pharmacoeconomics 7 1995 280 283
12. WHO Collaborating Center for Drug Statistics Methodology Anatomical therapeutical chemical (ATC) classification index including defined daily doses (DDDs) 1995 WHO Oslo
13. M. Bassetti, A. Di Biagio, B. Rebesco, G. Cenderello, M.E. Amalfitano, and D. Bassetti Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy Int J Antimicrob Agents 16 2000 295 299
14. T.M. Hooton, D. Scholes, K. Gupta, A.E. Stapleton, P.L. Roberts, and W.E. Stamm Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial JAMA 293 2005 949 955
15. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. 13th informational supplement M100-S13 2003 NCCLS Wayne, PA, USA
16. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
17. P.A. Clavien, J. Barkun, M.L. de Oliveira, and et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
18. V. Spoorenberg, M.E. Hulscher, R.P. Akkermans, J.M. Prins, and S.E. Geerlings Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay Clin Infect Dis 58 2014 164 169
19. J.J.1 Rahal, C. Urban, D. Horn, and et al. Class restriction of cephalosporins use to control total cephalosporins resistance in nosocomial Klebsiella JAMA 14 1998 1233 1237
20. W.R. Jarvis Preventing the emergence of multi-drug microorganisms through antimicrobials use controls: the complexity of the problem Infect Control Hosp Epidemiol 17 1996 490 495
21. B. Spellberg, R. Guidos, D. Gilbert, and et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America Clin Infect Dis 46 2008 155 164
22. C. Bantar, B. Sartori, E. Vesco, and et al. A hospital wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance Clin Infect Dis 37 2003 180 186
23. M.E. Falagas, I.A. Bliziotis, A. Michalopoulos, and et al. Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance J Chemother 19 2007 178 184
24. M.I. Gomez, S.I. Acosta-Gnass, L. Mosqueda-Barboza, and J.A. Basualdo Reduction in surgical antimicrobial prophylaxis expenditure and the rate of surgical site infection by means of a protocol that controls the use of prophylaxis Infect Control Hosp Epidemiol 27 2006 1358
25. American Urological Association Best practice policy statement on urologic surgery antimicrobial prophylaxis 2007 AUA Washington, DC https://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis.pdf
26. C. Bantar, E. Vesco, C. Heft, and et al. Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance Antimicrob Agents Chemother 48 2004 392 395
27. C. Kosmidis, M. Giannopoulou, A. Flountzi, and et al. Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns J Chemother 25 2013 217 221
28. M.J. Zervos, E. Hershberger, D.P. Nicolau, and et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000 Clin Infect Dis 37 2003 1643 1648
29. G. Aubert, A. Carricajo, A.C. Vautrin, and et al. Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit J Hosp Infect 59 2005 83 89
30. European Centre for Disease Prevention, Control Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2013 ECDC Stockholm http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf
31. T.E. Bjerklund Johansen, M. Cek, K. Naber, and et al. Prevalence of hospital-acquired urinary tract infections in urology departments Eur Urol 51 2007 1100 1111